Company news
Chongqing Zhifei Biological Products Co., Ltd. Class A (SZSE:300122) news
Chongqing Zhifei Biological Products Co., Ltd. Class A news releases on 6ix. Latest, Apr 28, 2026: Chongqing Zhifei Biological Products Co: First annual net…
View Chongqing Zhifei Biological Products Co., Ltd. Class A →
Press releases & updates
Chongqing Zhifei Biological Products Co: First annual net loss driven by industry downturn and asset impairment, but liquidity and R&D held firm
April 27, 2026
Zhifei Biological Products' Q3 Net Loss At 601.1 Million Yuan
October 29, 2025
Chongqing Zhifei Biological Products Co: Revenue and profit declined sharply, but R&D and cash flow remained robust
August 19, 2025
Chongqing Zhifei Biological Products Co: Q1 2025 saw a sharp revenue drop and net loss amid weak sales and rising costs
April 22, 2025
Chongqing Zhifei Biological Products Co: 2024 saw a 50%+ drop in revenue and profit, prompting a strategic focus on R&D and resilience
April 21, 2025
Chongqing Zhifei Biological Products Co: Revenue and profit plunged amid weak sales, negative cash flow, and rising short-term debt
October 25, 2024
Chongqing Zhifei Biological Products Co: H1 2024 revenue and profit declined sharply, but R&D and market leadership continued
August 29, 2024